Abstract: Accurate tumor diagnosis is important in highly conformal techniques such as Intensity Modulated radiotherapy (IMrT), which aims for high therapeutic ratio. We compared gross Tumor Volume (gTV) (primary and nodal) delineated on 18 F-fluorodeoxyglucose positron emission tomography ([ 18 F]-FDg-PeT) scan to those delineated on contrast-enhanced computed tomography (CeCT) scan and its impact on staging treated by IMrT. A total of 30 consecutive patients with locally advanced squamous cell carcinoma of head and neck were included in this study. FDg-PeT and CeCT scans were performed with dedicated positron emission tomography-computed tomography (PeT/CT) scanner in a single session as part of radiotherapy treatment planning for IMrT. After treatment with concurrent chemoradiotherapy, all patients were followed for one year. Three out of 30 patients were excluded from the final analysis, as there was complete remission in PET/CT after neoadjuvant chemotherapy. For remaining 27 cases, the primary sites were 17 oropharynx, 2 hypopharynx, 7 larynx and 1 unknown primary with secondary neck node. PeT-CT resulted in changes of CT-based staging in 25% patients (upstaged in 3 and down-staged in 4). gTV delineated on PeT vs. CT scan was gTV-PeT ( 
Introduction
Head and neck cancers (HNCs) are the sixth most common cancers worldwide causing 300,000 deaths annually. squamous cell carcinomas form the major histology [1, 2] . radio therapy with concurrent chemotherapy has demonstrated improved treatment outcome in locally advanced head and neck cancer. Intensity Modulated radio therapy (IMrT) has shown benefits in lowering the toxicities as well as in improving loco-regional control in these patients [3] [4] [5] . A small error in target delineation can increase the possibility of recurrences in IMrT. so, apart from anatomical delineation, functional imaging may improve outcome with IMRT. PeT and CT images, allow the acquisition of whole body anatomic and functional images of a patient in one single procedure [6] . [ 18 F]-FDg-PeT has recently been used to verify the target volume in radiotherapy treatment planning for various malignancies, especially non-small cell lung cancer, head and neck cancer, etc. [7] [8] [9] . In this study, we compared quantitatively GTV delineated on [ 18 F]-FDgPeT/CT scan to those delineated on contrast-enhanced computed tomography scan (CeCT scan) in locally advanced head and neck cancers and clinical outcome analysis of positron emission tomography-computed tomography (PeT/CT) in combination with IMrT.
Materials and methods
Prospectively, 30 patients of locally advanced head and neck cancer were analyzed from January 2014 to January 2016, after approval by institutional ethics committee. The inclusion criteria are: (i) locally advanced oropharyngeal, hypopharyngeal and laryngeal cancer (stages III, IVA and IVB); (ii) age: 18-70 years; (iii) Karnofsky Performance score (KPs): 70%-90%; and (iv) hemoglobin >10 gm/dl, total leucocyte count >4000/mm 3 , platelet >1 lakh/mm 3 and serum creatinine <1.50 mg/dL. Exclusion criteria are: (i) primary site of nasopharynx and oral cavity, (ii) patients who have undergone primary surgery, (iii) hypersensitivity to contrast, (iv) previously irradiated patients in head and neck. An informed consent was taken before enrolling patients in the study. A detailed counseling was done on concurrent chemoradiotherapy and PeT/CT-based radiotherapy planning.
Preparing the patient
Patients were immobilized in supine position using a fiveclamp customized thermoplastic mask on appropriate neck rest. FDg, the patients were asked to wait in a quiet room for one hour. Patients were instructed to minimize any talking, chewing, swallowing or movement of the head because these activities can influence the muscular uptake in the masticator muscles, tip of the tongue, face, neck and larynx. For patients with Diabetes Mellitus II, the upper level of plasma glucose was <150 mg/dL. The examination was started one hour after injection. The diagnostic PeT/ CT and radiotherapy planning PeT/CT were performed in subsequent sessions on the same day. First, diagnostic PeT/CT was done, and the field of view for diagnostic PeT/CT was from skull to below the knees. PeT/CT was performed using the siemens Biograph 16 PET/CT scanner (Lutetium Oxyorthosilicate-based 16-slice scanner). The diagnostic PeT/CT was performed on a curved couch top. After completion of diagnostic PeT/ CT, the tabletop was changed to flat one for PET/CT IMRT planning. radiotherapy planning PeT scan and CeCT scan were done in same session in treatment position on a flat top with immobilization face mask and proper alignment with the help of lasers.
The parameters used for PeT and CT are as follows: The PeT acquisition was performed with the field of view from scalp to D4 vertebral level, and acquisition time was 120 s/bed position. Immediately following the acquisition of the PeT scan, IV contrast of 70 ml Omnipaque (Iohexol injection) was administered. CECT scan was performed with a slice thickness of 3 mm. This CeCT scan was used for IMrT planning. The procedure required approximately 15 min to position the patient and to acquire both the PeT and CT data in total. All data was sent through DICOM (Digital Imaging and Communications in Medicine) to a workstation treatment planning system (TPs) (eclipse TM integrated treatment planning system version 10, (Varian Medical systems, Palo Alto, UsA) through local area network (LAN). After importing, CeCT scans were fused (by rigid registration method) with the PeT images acquired using inbuilt software in the eclipse TM treatment planning system. Table 1 illustrates the difference between Venkada et al. and our study in image acquisition, registration and delineation [10] . Table 1 . Difference between Venkada et al. [10] and our study in image acquisition, registration and delineation Venkada et al.
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Our study
• studied about PeT/CT-based target delineation of gTV primary and node only.
•
Primary and nodal gTV volumes on PeT/CT and CT were significantly different (p < 0.001).
• gTV-PeT volumes are smaller than gTV-CT for primary and node.
• studied about PeT/CT-based target delineation of gTV primary and node. All patients were followed at least once a week during radiotherapy. After the completion of radiation patients were evaluated at 1 st , 3 rd , 6 th and 12 months.
• Analyzed whether PET-based contouring do have any effect on locoregional control.
• Primary and nodal gTV volumes on PeT/CT and CT were statistically insignificant.
• gTV-PeT volumes are larger than gTV-CT for primary and node.
Image acquisition:
• All patients fasted at least 12 hours prior to PeT/CT. • Administered 375 MBq of 18 F-FDg.
• Did not mention about plasma glucose levels to be maintained in diabetic patients before PeT/CT.
•
Field of view for diagnostic PeT/CT was from skull to upper thigh.
Field of view for IMrT planning CT was from frontal sinus to D4 vertebra level.
• Following acquisition of PeT scan, IV contrast 40 mL was injected.
CeCT scan was performed with a slice thickness of 5 mm.
• All patients fasted for 6 hours prior to PeT/CT. • Administered 370 MBq (10 mCi) of 18 F-FDg.
• For patients with Diabetes Mellitus II, the upper level of plasma glucose was <150 mg/dL.
Field of view for diagnostic PeT/CT was from skull to below the knees.
Field of view for IMrT planning CT was from scalp to D4 vertebra level.
• 70 ml of Omnipaque (Iohexol injection) injected.
CeCT scan was performed with a slice thickness of 3 mm.
Registration:
• CeCT scans were fused with PeT images acquired in the treatment planning position using inbuilt software in the siemens' Coherence-Oncologist Treatment Planning System
• CeCT scans were fused with PeT images by rigid registration method.
Delineation:
• Used visual interpretation method for gTV-PeT delineation of primary and node.
•
Did not mention about target volume treated by IMrT (either gTV-PeT or gTV-CT or gTV PeT + CT).
• For treatment purpose, PeT target margins were taken into consideration in redefining the CT contours to create a final contour (gTV-PeT + CT, used to generate CTV and PTV).
Delineation of GTV
The primary tumor and abnormal lymph nodes in the neck were delineated on CeCT scan. While contouring on CeCT scans, PeT images were completely blinded. gross Tumor Volume CT (gTV-CT) was delineated on planning CeCT scans. Lymph nodes with >10 mm in shortest dimension, perinodal extension and necrosis in center were included in gTV-CT node. Once contouring on CeCT scans has been done, these images were blinded while contouring on PET. GTV-[ 18 F]-FDg-PeT/CT (gTV-PeT) was delineated using visual interpretation method. The window level of the PET images was adjusted to adequately visualize [
18 F]-FDg-avid lesions relative to background normal organs, such as heart and liver. Once the CT and PeT contours were complete, we reviewed the original CT contours and PeT contours simultaneously. The PeT target margins were then taken into consideration in redefining the CT contours to create a final contour (GTV PET + CT, used to generate CTV and PTV) that represented a compromise between CTand PET-defined targets. The absolute GTV-CT and image fusion gTV-PeT volumes were measured. The volumes of intersecting areas were delineated for the purpose of comparison.
This was followed by the delineation of target and organs at risk by creating Clinical Target Volume (CTV 1 : high risk volume enclosing the gross tumor volume; and CTV 2 : low risk volume of elective nodal regions), Planning Target Volume (PTV 1 : CTV 1 + 0.5 cm; and PTV 2 : CTV 2 + 0.5 cm), parotid glands, oral cavity, lips, spinal cord, brain stem and mandible. IMrT plans were generated with sliding window technique using nine coplanar equidistant fields of 6 MV energy. Optimizations and dose calculations were done with eclipse TM version 10 (Varian Medical systems, Palo Alto, UsA). All IMrT optimizations were done interactively by adapting the objectives and their priorities. IMrT plan objectives were to achieve PTV volumes receiving <95% of the prescribed dose (V < 95) of <1% and V > 107% close to zero. Dose prescription to PTV was: (weekly cisplatin injection regimen) and radiotherapy.
Follow-up
All patients were followed at least once a week during radio therapy. After the completion of radiation patients were evaluated at 1, 3, 6 and 12 months.
Loco-regional control was defined as from date of diagnosis until date of first loco-regional recurrence, stable disease or disease progression.
Statistical analysis
Continuous variables were summarized as mean and standard deviations while nominal/categorical variables as proportions (%). Unpaired 't' test was used for comparison of continuous variables. survival analysis was done for disease-free survival and event-free survival. survival rates with 95% confidence interval were calculated. Median survival period was also calculated. 'p' value <0.05 was taken as significant. MedCalc 14.2.1.0 version software was used for all statistical calculations.
The mismatch between two volumes was analyzed by following method (Figure 1 
Results
Three out of 30 patients were excluded from study, as there was complete remission in PeT/CT after neoadjuvant chemotherapy. The demographic characteristics of all patients are shown in Table 2 . The distribution of all staging patterns of 27 patients for T, N and M categories is shown in Table 3 . PeT scan changed the CT-based staging in seven cases (25.93%). Three cases (11.11%) were upstaged (III to IVA, IVA to IVC, and IVB to IVC) and four cases (14.81%) were down-staged by PeT/CT scan (stage III to II). In patient no. 19 with unknown primary with secondaries in neck, PeT/CT identified a primary in the posterior pharyngeal wall. 
Nodal GTV changes
The median value of gTV-CT node was 5.63 cm 3 (range:
1.02-86.17 cm 3 ) and mean was 21.56 ± 31.28 cm 3 . The median value of gTV-PeT node was 5.78 cm 3 (range:
0.00-149.96 cm 3 ) and mean was 28.45 ± 45.46 cm 3 . The mean value of gTV-PeT and gTV-CT was not statistically significant (p = 0.589). The gTV-PeT node was larger than gTV-CT node in 10 cases (52.63%) and smaller in 9 cases (47.37%).
The median value of percentage of mismatch of nodal gTV-PeT to gTV-CT was 33.50% (range: 0.00%-254.18%) and mean was 53.46% ± 57.07%. The median value of percentage of mismatch of nodal gTV-CT to gTVPeT was 29.66% (range: 2.43%-90.30%) and mean was 33.64% ± 26.04%. Mismatch of nodal gTV-PeT to nodal GTV-CT was statistically not significant (p = 0.187).
The median value of percentage of nodal gTV-PeT covered by gTV-CT was 69.18% (range: 0.00%-95.78%) and mean was 64.46% ± 23.08%. The median value of percentage of nodal gTV-CT covered by gTV-PeT was 63.93% (range: 23.23%-94.96%) and mean was 60.99% ± 18.95%. Coverage of nodal gTV-PeT to gTV-CT was statistically insignificant (p = 0.622).
PeT scan changed the nodal gTV-CT with a median value of 9.18% (range: -56.12%-69.8 %). The median value of nodal gTV-PeT outside CT scan was 0.69 cm were graded on CTCAe v4.03 and grade 1, 2 and 3 oral mucositis 16%, 56% and 28%, respectively. grade 1, 2 and 3 skin reactions were 56%, 40% and 4%, respectively. After a median follow-up of 12 months, 1 (4%) had local failure, 1 (4%) had nodal failure and no distant failure.
Discussion
The therapeutic index in radiation therapy can be improved with better target volume delineation. This is especially true in head and neck cancers where organs at risk are in close proximity to these targets and highly conformal therapies may reduce toxicities. The use of FDG-PET/CT prior to treatment has benefitted in potential improvement of tumor staging and better delineation of target volume (utilizing anatomical and biological data) [111] .
Incorporating PeT/CT in the management of head and neck cancers resulted in significant changes in clinical staging. Wang et al. evaluated 28 patients with head and neck carcinoma and the impact of FDg-PeT fused with planning CT scans on tumor localization. PeT/CT changed CT-based staging in 16 of 28 (57%) of patients [12] .
Deantonio et al. analyzed the use of [
18 F]-FDg-PeT/CT images for staging and target volume delineation of patients with head and neck carcinoma; PeT/CT imaging changed the TNM categories in 5 of 22 (22%) cases when compared with CT alone [123] . In our study also, PeT/CT changed CTbased clinical staging in 25% of patients (7/27 ). In two of our patients (7.4%), distant metastasis was seen and treatment approach was changed from curative to palliative. Kajitani et al. suggested that FDg-PeT is effective for defining gTV in radiotherapy treatment planning for squamous cell carcinoma head and neck. PeTgTV evaluated by both CeCT and FDg-PeT images is preferable to CT-gTV by CeCT alone [134] .
Multiple methods were proposed for accurate contouring of gTV in PeT/CT fusion-guided radiotherapy, such as visual interpretation method, a fixed 50% threshold of the background-subtracted tumor maximum uptake (THR), and software-based automated segmentation. Visual comparison of FDg-PeT images and CT simulation was utilized in this study [145] . however, this method is highly operatordependent since the settings of images may be arbitrarily controlled-choosing different window levels would result in significantly different apparent tumor volumes. Schinagl et al. generated gTV VIs (PeT-based gTV obtained by visual interpretation) in 77 patients and observed gTV CT and gTV VIs yielded similar volumes. The mean absolute gTV derived from the visual interpretation of PeT images was similar to gTV CT . however, the other three thresholdbased PeTs (gTV 40% , gTV 50% and gTV sBr ) were smaller than gTV CT (p < 0.0001) [156] . In Kumar et al., PeT/CT was used for target delineation of seven head and neck cancer patients and PeT delineated volume (gTV-PeT) was significantly higher (10%-50%) than CT delineated volume (gTV-CT) for local site, but for regional targets, the difference was <10% [167] . In our study, PeT/CT-based gTVs of primary tumor were larger than CTbased gTV in 55% (15/27) of patients and, similarly, PeTbased nodal gTVs were larger in 52% of cases. Venkada et al. reported that gTV-PeT was significantly smaller than gTV-CT (p < 0.001) [170] . Image acquisition procedures, registration methods and target volume delineation methods might be potential factors for this variation.
Mismatch analysis is a potential tool to study the disagreement between CT and PeT/CT in the contouring of gTV. eI-Bassiouni et al. found the mean value for mismatch of gTV-PeT to gTV-CT as 28.9% ± 32.9% and the mismatch of gTV-CT to gTV-PeT as 70.9% ± 50.9% [18] . Venkada et al. found that the mismatch gTV-PeT to gTV-CT was significantly smaller than the mismatch gTV-CT to gTV-PeT (p = 0.03) [170] . In our study, for primary, the mean of mismatch of gTV-PeT to gTV-CT was larger than gTV-CT to gTV-PeT. The mismatch of GTV-PET to GTV-CT was not statistically significant with CT to PeT (p = 0.635). In our study, the coverage of gTV-PeT to gTV-CT and gTV-CT to gTV-PeT was analyzed to evaluate the difference between the two gTV volumes and was found not statistically significant (p = 0.961). el-Bassiouni et al. studied that the median percentage of the gTV-PeT covered by gTV-CT was 99.5%, whereas the median percentage of gTV-CT covered by gTV-PeT was 95.1% (p = 0.2) [18] . In this study, the mean value of percentage of primary gTVPeT covered by gTV-CT was 60.40% + 21.84%, whereas the percentage of primary gTV-CT covered by gTV-PeT was 60.09% + 22.78%. All curative patients (25) in this study completed their planned courses of IMrT and chemotherapy. The one-year loco-regional control was 92%. rothschild et al. analyzed 45 patients with oro-or hypo-pharyngeal carcinoma, and found that PeT/CT-guided IMrT improved cure rates compared to patients undergoing without PeT/CT and three-dimensional conformal radiotherapy (3DCrT) [19] . The loco-regional failure-free rates at 1 year was 93% in IMrT group and 73% in controls, and at 2 year were 83% and 63%, respectively (p = 0.01).
The results of our study suggest that the superiority of PeT/CT for the delineation of target volumes by visual interpretation method in the head and neck carcinoma radiotherapy planning is yet to be proven. It has to be confirmed prospectively with larger study populations before PeT/CT can be implemented in routine use for radiotherapy planning of head and neck cancer.
Conclusion
PeT scan changed 25% of CT scan-based staging, altering the T, N and M staging. PeT/CT has the potential to identify gTV outside CT-based gTV that increases accuracy of radiation planning.
Author contributions
N Burela collected, analzed and interpreted the data. All authors read and edited the final manuscript.
